Literature DB >> 15193408

Can oral cholera vaccination play a role in controlling a cholera outbreak?

Philippe Calain1, Jean-Paul Chaine, Eliaser Johnson, Mary-Lou Hawley, Michael J O'Leary, Hitoshi Oshitani, Claire-Lise Chaignat.   

Abstract

Control measures to limit the spread of a cholera outbreak in Pohnpei Island (Micronesia), included mass vaccination with the single-dose live-attenuated oral cholera vaccine CVD 103-HgR as a potential adjunct measure. The outbreak provided a unique opportunity to evaluate the practicality of use and effectiveness of this vaccine. Under field conditions encountered in Pohnpei, crude vaccine efficacy was estimated at 79.2% (95% CI: 71.9-84.6%) in the target population. Retrospective analysis suggests that mass vaccination with oral cholera vaccines can be a useful adjunct tool for controlling outbreaks, particularly if implemented early in association with other standard control measures.

Mesh:

Substances:

Year:  2004        PMID: 15193408     DOI: 10.1016/j.vaccine.2003.11.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

Review 1.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

2.  Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004.

Authors:  Brian S Schwartz; Jason B Harris; Ashraful I Khan; Regina C Larocque; David A Sack; Mohammad A Malek; Abu S G Faruque; Firdausi Qadri; Stephen B Calderwood; Stephen P Luby; Edward T Ryan
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

3.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

Review 4.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 5.  Vaccines in the time of cholera.

Authors:  John D Clemens
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-11       Impact factor: 11.205

6.  An overview of VaxchoraTM, a live attenuated oral cholera vaccine.

Authors:  Tarun Saluja; Vijayalaxmi V Mogasale; Jean-Louis Excler; Jerome H Kim; Vittal Mogasale
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

7.  Mitigating Cholera in the Aftermath of Cyclone Idai.

Authors:  Wilbur H Chen; Andrew S Azman
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

8.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

9.  The ARM Network--a model for infectious disease surge response capacity in the Western Pacific Region.

Authors:  Shoaib Hassan; Martyn Kirk; Tony Stewart; C Raina MacIntyre
Journal:  Western Pac Surveill Response J       Date:  2014-06-16

10.  Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO.

Authors:  Claire-Lise Chaignat; Victoria Monti
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.